Smith TT, Moffett HF, Stephan SB, Opel CF, Dumigan AG, Jiang X, Pillarisetty VG, Pillai SPS, Wittrup KD, Stephan MT. Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumor. Journal of Clinical Investigation. 2017 Jun 1;127(6):2176-2191.
Sirkka B. Stephan, Alexandria M. Taber, Ilona Jileaeva, Ericka P. Pegues, Charles L. Sentman and Matthias T. Stephan. Biopolymer implants enhance the efficacy of adoptive T cell therapy. Nature Biotechnology. 33, 97-101 (2015).
Matthias T. Stephan, Straight Shooters: Peptibodies Takes Aim.
Sci Transl Med 11 June 2014: Vol. 6, Issue 240, p. 240ec102
(Editor’s Choice article on Qin et al., Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice. Nature Medicine. published online 25 May 2014).
Matthias T. Stephan, Carbon Nanotubes Are Picky Hitchhikers.
Sci Transl Med 30 April 2014: Vol. 6, Issue 234, p. 234ec77
(Editor’s Choice article on B. R. Smith et al., Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat. Nanotechnol., published online 13 April 2014).